Shareholders Meetings

Share capital and voting rights*

  • Share capital: €5,034 582.90
  • Number of shares outstanding: 100,691,658
  • Total number of voting rights: 106,134,467

*As of May 31, 2026

6
Dec 2023
10:49 E.S.T.

Voting Form – Shareholder’s General Meeting December 22, 2023

Download the PDF file
17
Nov 2023
11:57 E.S.T.

Shareholders’ General Meeting Notice – December 22, 2023

Download the PDF file
28
Jun 2023
14:50 E.S.T.

Vote results – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
14:38 E.S.T.

Statutory auditors’ report on related party agreements 2022 – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
14:37 E.S.T.

Statutory auditors’ report on the consolidated financial statements 2022 – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
14:37 E.S.T.

Statutory auditors’ report on the financial statements 2022 – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
14:34 E.S.T.

Statutory auditors’ report on the issue of ordinary shares and various marketable securities giving access to other equity securities with and/or without cancellation of preferential subscription rights – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
14:33 E.S.T.

Statutory auditors’ report on the capital increase reserved for employees who are members of a company savings scheme – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
14:01 E.S.T.

Statutory auditors’ report on the allocation of free existing shares or free shares to be issued – Shareholders’ meeting 2023

Download the PDF file
13
Jun 2023
13:02 E.S.T.

Statutory auditors’ report on the authorization for the allocation of stock options or share purchase plans – Shareholders’ meeting 2023

Download the PDF file

Get updates

Get the latest on gene-editing innovation, financial and business news from Cellectis with our email alert service.

Subscribe now